Brachytherapy投稿须知

期刊简介

《Brachytherapy》是由Elsevier Inc.出版社于2002年创办的英文国际期刊（ISSN: 1538-4721，E-ISSN: 1873-1449），该期刊长期致力于肿瘤学领域的创新研究，主要研究方向为医学-核医学。作为SCIE收录期刊（JCR分区 Q3，中科院 4区），本刊采用OA未开放获取模式（OA占比0.0233...%），以发表肿瘤学领域等方向的原创性研究为核心（研究类文章占比90.10%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在101篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Brachytherapy审稿周期约为较慢,6-12周约9.1周。该刊近年未被列入国际预警名单，年发文量约101篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
101 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 4区	ONCOLOGY 肿瘤学 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学 4区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 3区	ONCOLOGY 肿瘤学 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学 4区 4区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q4	250 / 322	22.5%
学科：RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING	SCIE	Q3	118 / 204	42.4%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q3	220 / 322	31.83%
学科：RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING	SCIE	Q3	128 / 204	37.5%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：3.4

SJR：0.593

SNIP：0.785

学科类别	分区	排名	百分位
大类：Medicine 小类：Radiology, Nuclear Medicine and Imaging	Q2	155 / 333	53%
大类：Medicine 小类：Oncology	Q3	234 / 404	42%

期刊发文

Image-guided brachytherapy following external-beam radiation therapy for patients with inoperable endometrial cancer
Author: Huang, Chi-Hsien; Liang, Ji-An; Hung, Yao-Ching; Yeh, Lian-Shung; Chang, Wei-Chun; Lin, Wu-Chou; Chang, Yin-Yi; Chen, Shang-Wen

Journal: BRACHYTHERAPY. 2023; Vol. 22, Issue 1, pp. 72-79. DOI: 10.1016/j.brachy.2022.09.004
Evaluating the accumulated dose distribution of organs at risk in combined radiotherapy for cervical carcinoma based on deformable image registration
Author: Zhao, Tiandi; Chen, Yi; Qiu, Bin; Zhang, Jiashuang; Liu, Hao; Zhang, Xile; Zhang, Ruilin; Jiang, Ping; Wang, Junjie

Journal: BRACHYTHERAPY. 2023; Vol. 22, Issue 2, pp. 174-180. DOI: 10.1016/j.brachy.2022.09.001
Clinical efficacy and safety analysis of CT-guided 125 I implantation in the treatment of recurrent or metastatic pelvic malignant tumor
Author: Zhang, Shenghe; Chen, Songbai; Wang, Ruoyu; Wang, Zhe; Zhou, Jun; Li, Chuang

Journal: BRACHYTHERAPY. 2023; Vol. 22, Issue 2, pp. 132-138. DOI: 10.1016/j.brachy.2022.10.007
Dosimetric evaluation of iodine-125 brachytherapy for brain tumors using MR guidance combined with a three-dimensional non co-planar template
Author: Zhang, Menglong; Liu, Guitao; He, Xiangmeng; Chu, Cunkun

Journal: BRACHYTHERAPY. 2023; Vol. 22, Issue 2, pp. 242-249. DOI: 10.1016/j.brachy.2022.11.008
Role of brachytherapy in post-operative cervical cancer patients with risk factors other than positive stump
Author: Yu, Xiao-Li; Hu, Jiang; Cai, Xin-Ling; Fang, Jian-Nan; Yang, Jin; Luo, Ming; Bai, Shou-Min

Journal: BRACHYTHERAPY. 2023; Vol. 22, Issue 2, pp. 166-173. DOI: 10.1016/j.brachy.2022.10.002
125I seeds implantation for treating residual hepatocellular carcinoma located beneath the diaphragm after transcatheter arterial chemoembolization
Author: Jie Li, Lijuan Zhang, Qigen Xie, Weiguo Wang, Yanyan Hua, Leyuan Zhou, Zongqiong Sun

Journal: Brachytherapy, 2019, Vol., , DOI:10.1016/j.brachy.2018.12.008
Evaluation of the accuracy of computer-assisted techniques in the interstitial brachytherapy of the deep regions of the head and neck
Author: Guo-Hao Zhang, Xiao-Ming Lv, Wen-Jie Wu, Zhi-Yuan Wu, Lei Zheng, Ming-Wei Huang, Yong Wang, Jian-Guo Zhang

Journal: Brachytherapy, 2019, Vol., , DOI:10.1016/j.brachy.2018.12.003
Predictive factors of benefit from iodine-125 brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis
Author: Junqing Lin, Han Jiang, Weizhu Yang, Na Jiang, Qubin Zheng, Ning Huang, Xiaolong Wang, Ang Li, Jingyao Huang

Journal: Brachytherapy, 2018, Vol., , DOI:10.1016/j.brachy.2018.10.002

Brachytherapy

近距离放射治疗

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询